Compounds > etoposide
Page last updated: 2024-08-23

etoposide and Burkitt Lymphoma

etoposide has been researched along with Burkitt Lymphoma in 108 studies

Research

Studies (108)

TimeframeStudies, this research(%)All Research%
pre-19904 (3.70)18.7374
1990's18 (16.67)18.2507
2000's37 (34.26)29.6817
2010's39 (36.11)24.3611
2020's10 (9.26)2.80

Authors

AuthorsStudies
Allison, DL; Glaser, R; Holliday, JE; Kamat, PL; Liebowitz, SM; Moeschberger, ML; Schaller, JP; Witiak, DT1
Arun, VA; Bal, A; Jain, A; Malhotra, P1
Allione, B; Angelillo, P; Cattaneo, C; Erbella, F; Facchetti, F; Ferreri, AJM; Flospergher, E; Foppoli, M; Lleshi, A; Pagani, C; Pecciarini, L; Ponzoni, M; Re, A; Rossi, G; Sassone, M; Spina, M; Steffanoni, S; Verga, L1
Li, Z; Qin, Y; Sang, W; Song, X; Sun, C; Tu, D; Wang, X; Xu, K; Xu, L; Yan, D; Yin, W; Zeng, L; Zhang, M1
Kobbe, R; Schmidtke, S; Schwärzler, P; Stang, A; Tolosa, E1
Abramson, JS; Bartlett, NL; Bierman, PJ; Dunleavy, K; Fanale, MA; Friedberg, JW; Hanna, WT; Jaffe, ES; Jagadeesh, D; Kahl, BS; Link, BK; Little, RF; Lucas, AN; Melani, C; Mitsuyasu, RT; Noy, A; Patel, P; Peace, D; Pittaluga, S; Powell, BL; Roschewski, M; Steinberg, SM; Watson, PR; Wilson, WH1
Jain, A; Jindal, N; Khadwal, A; Lad, D; Malhotra, P; Prakash, G1
Dunleavy, K; Roschewski, M; Wilson, WH1
Gandhi, MK; Hertzberg, M; Joske, DJL1
Allione, B; Calimeri, T; Cattaneo, C; Donadoni, G; Facchetti, F; Ferrari, D; Ferreri, AJM; Foppoli, M; Fumagalli, L; Lleshi, A; Pecciarini, L; Ponzoni, M; Re, A; Rigacci, L; Rossi, G; Sassone, M; Spina, M; Verga, L1
Colton, BS; Glaspy, J; Hornstein, N; Larson, S; Timmerman, J1
Baars, JW; Brouwer, R; Chamuleau, MED; de Jong, D; de Wreede, LC; Demandt, AMP; Doorduijn, JK; Hardi, L; Kersten, MJ; Kluin, PM; Nijland, M; Oosten, LEM; Siemes, C; Smeekes, OS; Stevens, WBC; Thielen, FW; Uyl-de Groot, CA; van Imhoff, GW; Veelken, H1
Ambinder, RF; Hunter, NB; Vogt, S1
Abou Mourad, Y; Barnett, MJ; Broady, R; Connors, JM; Forrest, DL; Gerrie, AS; Hogge, DE; Leitch, H; Nantel, SH; Narayanan, S; Nevill, TJ; Power, MM; Ramadan, K; Sanford, DS; Sehn, LH; Slack, GW; Song, KW; Sutherland, HJ; Toze, CL; Tucker, T; Zhu, KY1
Eisenman, K; Maloney, KW; Ross, S1
Nitta, H1
Aladjidi, N; Auperin, A; Couec, ML; Gandemer, V; Haouy, S; Jourdain, A; Lambliotte, A; Landman-Parker, J; Leblanc, T; Michon, J; Minard-Colin, V; Patte, C; Plat, G; Rigaud, C1
Brown, PN; D'Amore, F; Hagberg, H; Hagberg, O; Jerkeman, M; Pedersen, LM; Wästerlid, T1
Aurer, I; Bašić-Kinda, S; Grah, JJ; Ilić, I; Radman, I1
Barr, PM; Caimi, PF; Carson, KR; Evens, AM; Gordon, LI; Gregory, SA; Helenowski, I; Islam, N; Jovanovic, B; Kolesar, J; Nabhan, C1
Cole, D; Dunleavy, K; Grant, C; Jaffe, ES; Little, RF; Pittaluga, S; Shovlin, M; Staudt, LM; Steinberg, SM; Widemann, B; Wilson, WH1
Ajisawa, A; Hagiwara, S; Kitanaka, A; Kojima, Y; Nagai, H; Okada, S; Tanuma, J; Uehira, T1
Ferreira, AC; Klumb, CE; Rezende, LM; Robaina, MC; Severino, P1
Anderson, JR; Barth, M; Cairo, MS; Frazer, JK; Galardy, P; Goldman, S; Gross, TG; Harrison, L; Perkins, SL; Sanger, W; Shiramizu, B; Smith, L; Weinstein, H1
Jacobson, C; LaCasce, A1
Maruyama, D2
Beck, J; Burmeister, T; Dengler, J; Döhner, H; Domanska-Czyz, K; Dührsen, U; Fietkau, R; Gökbuget, N; Hertenstein, B; Hiddemann, W; Hoelzer, D; Horst, HA; Hüttmann, A; Kneba, M; Reichle, A; Rieder, H; Schaich, M; Schmidt-Wolf, IG; Schwartz, S; Serve, H; Spiekermann, K; Thiel, E; Viardot, A; Walewski, J1
Ando, K; Kikuchi, T; Kikuti, YY; Kojima, M; Moriuchi, M; Murayama, H; Nakamura, N; Ogawa, Y; Tokunaka, M; Tsuboi, K; Yabe, M1
Hoelzer, D1
Johnson, DH; Reske, T; Ruiz, M1
Adachi, S; Fujino, H; Heike, T; Hiramatsu, H; Hori, T; Kato, I; Saida, S; Umeda, K; Watanabe, K; Yamada, T1
Ambinder, R; Baiocchi, R; Cesarman, E; Kaplan, L; Lee, JY; Noy, A; Ratner, L; Reid, E; Wagner-Johnston, N1
Abramson, JS; Cassaday, R; Chavez, JC; Fenske, TS; Gandhi, M; Jaso, J; Landsburg, DJ; Medeiros, LJ; Nabhan, C; Petrich, AM; Press, O; Shah, N; Sohani, AR; Song, K; Yang, DT; Zelenetz, AD1
Bendle, M; Boffito, M; Bower, M; Dalla Pria, A; Ramaswami, R1
Gao, J; Guo, J; Guo, X; Jia, CS; Li, Q; Zhou, CY; Zhu, YP1
Dul, C; Khan, U1
Bhagat, VH; Sepe, T1
Blankenship, DW; Mauskar, MM; Nymeyer, H1
Cortes, JE; Estrov, Z; Ferrajoli, A; Garcia-Manero, G; Jabbour, E; Kantarjian, HM; Khouri, M; Khoury, JD; Ko, H; O'Brien, SM; Pierce, S; Ravandi, F; Short, NJ; Thomas, DA; Thompson, PA; Verstovsek, S; Wierda, WG1
Barrans, SL; Clawson, SM; Jack, AS; Mead, GM; Qian, W; Radford, JA; Stenning, SP; Walewski, J; Wolf, M; Yule, CL1
Choi, KA; Huh, W; Kim, DJ; Kim, K; Kim, WS; Kim, YG; Ko, YH; Lee, JE; Oh, HY1
Choi, MK; Jun, HJ; Kim, K; Kim, KH; Kim, SJ; Kim, WS; Ko, YH; Lee, SY; Lim, DH1
Garibal, J; Hollville, E; Pujals, A; Renouf, B; Tétaud, C; Wiels, J1
Jain, S; Kapoor, G; Naithani, R; Saha, R1
Klumb, CE; Maia, RC; Simões Magluta, EP; Vasconcelos, FC1
Baker, L; Cochrane, L; Delabie, J; Holte, H; Lauritzsen, GF; Mahendra, P; Roberts, C; Tauro, S1
Hayashi, H; Kakimoto, T; Kurai, H; Mihara, A; Nakazato, T; Sanada, Y; Suzuki, K; Tachikawa, N; Yoshida, S; Yoshimura, Y1
Lima, RT; Nascimento, MS; Seca, H; Soares, P; Vasconcelos, MH1
Azuma, T; Kim, SW; Kobayashi, Y; Maeshima, AM; Maruyama, D; Matsuno, Y; Mori, M; Munakata, W; Nomoto, J; Taniguchi, H; Tobinai, K; Watanabe, T1
Abramson, JS; Barnes, JA; Feng, Y; Hochberg, EP; Lacasce, AS; Michaelson, JS; Neuberg, D; Toomey, CE1
Araki, D; Fujii, Y; Hakomori, SI; Hosono, M; Kanaly, RA; Kawano, T; Kawsar, SM; Matsumoto, R; Miyagi, T; Nitta, K; Ozeki, Y; Sugawara, S; Takahashi, K; Takayanagi, M; Tatsuta, T; Yasumitsu, H1
Chiba, S; Enami, T; Hasegawa, Y; Kondo, Y; Nakamura, N; Nishikii, H; Noguchi, M; Okoshi, Y; Sakata-Yanagimoto, M; Suzukawa, K; Yokoyama, Y1
Dos Santos Ferreira, AC; Fernandes, RA; Klumb, CE; Kwee, JK1
Avci, Z; Gursel, O; Kurekci, E; Malbora, B; Olgac, A; Ozbek, N1
Adde, M; Adeodou, O; Aken'Ova, Y; Brown, BJ; Durosinmi, M; Githang'a, J; Hurwitz, N; Kaijage, J; Leoncini, L; Magrath, I; Naresh, K; Ngoma, T; Rajab, J; Raphael, M; Rohatiner, A; Scanlan, P; Venzon, D1
Grigg, A; Guarnaccia, C; Hatton, CS; Lewis, MS; McKendrick, J; Mead, GM; Norbert, P; Pescosta, N; Stenning, SP; Sydes, MR; Walewski, J; Wright, D1
Berkow, RL; Hilliard, LM; Watts, RG1
Levine, AM1
Al Awadi, S; Al Shemmari, S; Bajciova, V; Mottl, H; Nemec, J1
Corbacioglu, S; Eber, S; Gungor, T; Hummerjohann, J; Niggli, F1
Goy, A; Hedrick, E; Moskowitz, C; Noy, A; Portlock, C; Qin, J; Straus, DJ; Teruya-Feldstein, J; Wang, ES; Zelenetz, AD1
Brunet, S; Esteve, J; Feliu, E; Fernández-Abellán, P; Ribera, JM; Sanz, MA; Xicoy, B1
Fortney, JE; Gibson, LF; Wang, L1
Fisher, D; Howard, O; Lacasce, A; Lib, S; Neuberg, D; Shipp, M; Weng, A1
Benchekroun, S; Benhmiddoune, L; Harif, M; Madani, A; Quessar, A; Zafad, S1
Kluin, PM; Kluin-Nelemans, HC; Kramer, MH; MacKenzie, MA; Meulendijks, LA; Ossenkoppele, GJ; Raemaekers, JM; Schouten, HC; Sonneveld, P; van 't Veer, MB; van der Holt, B; van Imhoff, GW; van Marwijk Kooy, M; van Oers, MH; Verdonck, LF; Wijermans, PW1
Miyahara, S; Mizutani, M; Murabayashi, K; Ogawa, T; Yabana, T1
Bosq, J; Casassus, P; Diviné, M; Dupriez, B; Koscielny, S; Le Maignan, C; Pico, JL; Raphaël, M; Ribrag, V; Sebban, C; Stamattoulas, A1
Blennow, E; Ernberg, I; Fadeel, B; Henter, JI; Karpova, MB; Nordenskjöld, M; Schoumans, J; Smirnov, AF1
Dabbas, B; Ford, CD; Gabor, F; Morgan, R1
Lam, MS1
Abbott, BL; Chen, R; Myint, H1
Kenna, T; Mattarollo, SR; Nicol, AJ; Nieda, M1
Barberi, W; Foa, R; Giona, F; Malandruccolo, L; Mandelli, F; Martino, P; Moleti, ML; Palumbo, G; Paoloni, F; Pescarmona, E; Testi, AM1
Fujishima, M; Fujishima, N; Hirokawa, M; Inomata, M; Kameoka, Y; Saitoh, H; Saitoh, K; Sawada, K; Takahashi, N; Yamanaka, Y; Yoshioka, T1
Borie, R; Daniel, MT; Fieschi, C; Galicier, L; Gérard, L; Meignin, V; Oksenhendler, E1
Chatzimichael, A; Kalmanti, M; Katzilakis, N; Mantadakis, E; Raissaki, M; Tzardi, M1
Arceci, RJ; Blättler, WA; Corvi, C; Ferris, CA; Goldmacher, VS; Guild, BC; Lambert, JM; Liu, C; Liu, Y; O'Connor, R; Teicher, BA1
Dommann-Scherrer, C; Honegger, HP; Jacky, E; Jost, LM; Maurer, R; Sauter, C; Stahel, RA1
Gadner, H; Henze, G; Ludwig, WD; Müller-Weihrich, S; Parwaresch, R; Reiter, A; Riehm, H; Sauter, S; Schrappe, M; Sykora, KW1
Bae, I; Bhatia, K; el-Deiry, WS; Fan, S; Fornace, AJ; Freeman, J; Jondle, D; Kohn, KW; Magrath, I; O'Connor, PM1
Borowitz, MJ; Bowman, WP; Buchanan, GR; Jacaruso, D; Kamen, BA; McKenna, RW; Schneider, NR; Shuster, JJ; Winick, NJ1
Balkenende, AY; Slaper-Cortenbach, IC; van den Berg, H; van der Schoot, CE; Van Leeuwen, EF; Vervoordeldonk, SF; von dem Borne, AE1
Cattan, AR; Maung, ZT1
Burke, M; Crawford, DH; Hunt, BJ; Thomas, JA; Walker, H; Yacoub, M1
Cooper, DL; Levy, A; Salloum, E; Tallini, G1
Azar, N; Binet, JL; Boccaccio, C; Charlotte, F; Gabarre, J; Gentilini, M; Gonzalez, H; Jouan, M; Leblond, V; Sutton, L1
Hanazawa, T; Kimura, Y; Nagumo, M; Okano, T; Sakamaki, H; Yamaguchi, A1
Cross, S; Lavin, MF; Lees-Miller, SP; Misko, I; Song, Q; Zhao, EG1
Anami, K; Asami, K; Chin, M; Fujimoto, T; Hatae, Y; Hirota, T; Horikoshi, Y; Ito, M; Iwai, A; Kaneko, Y; Katano, N; Kataoka, S; Kikuchi, M; Koizumi, S; Miyawaki, T; Mugisima, H; Nakayama, M; Nishikawa, K; Osima, K; Suzumiya, J; Taga, T; Tanaka, A; Tsurusawa, M; Watanabe, A; Yanase, T1
Kondo, E; Miura, A; Mizuno, H; Yamao, H; Yuge, M1
Alessandri, JL; Attali, T; Dubern, B; Montbrun, A; Pilorget, H; Samperiz, S1
Lee, YJ; Shacter, E1
Bargetzi, M; Heitzmann, F; Obeid, L; Schär, B1
Chott, A; Ebell, W; Graf, N; Henze, G; Klingebiel, T; Kremens, B; Ludwig, WD; Mann, G; Müller-Weihrich, S; Plüss, HJ; Reiter, A; Riehm, H; Schrappe, M; Tiemann, M; Yakisan, E; Zimmermann, M; Zintl, F1
Dive, C; Hickman, JA; Taylor, ST1
Bushell, M; Clemens, MJ; Flotow, H; Lloyd, RE; Marissen, WE; Morley, SJ; Poncet, D1
Hinson, RM; Lee, YJ; Sentürker, S; Shacter, E; Williams, JA1
Atra, A; Gerrard, M; Hann, IM; Hobson, R; Imeson, JD; Pinkerton, CR1
James, K; Skibinska, A; Skibinski, G1
Levine, R; Morrow, J; Sentürker, S; Shacter, E; Tschirret-Guth, R1
Amir, G; Cohen, Y; Polliack, A; Rachmilewitz, EA1
Bieszczad, CK; Cleaveland, ES; Craig, RW; Ma, Y; Mohandas, TK; Park, JP; Vrana, JA1
Casanova, M; Cefalo, GS; Collini, P; Ferrari, A; Fossati-Bellani, F; Gasparini, M; Luksch, R; Massimino, M; Polastri, D; Spreafico, F; Terenziani, M1
Ardiet, C; Navarro, C; Sapet, C; Tranchand, B1
Brix, F; Gassmann, W; Heit, W; Hertenstein, B; Holthuis, JJ; Johannson, W; Rister, M; Schaub, J; Schmitz, N; Suttorp, M1
Ben-Sira, I; Cohen, S; Nissenkorn, I; Stark, B; Wysenbeek, YS; Zaizov, R1

Reviews

10 review(s) available for etoposide and Burkitt Lymphoma

ArticleYear
Successful Immunochemotherapy for Burkitt Lymphoma During Pregnancy as a Bridge to Postpartum High-Dose Methotrexate Therapy: A Case Report and Review of the Literature.
    Clinical lymphoma, myeloma & leukemia, 2020, Volume: 20, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Immunotherapy; Methotrexate; Postpartum Period; Prednisolone; Pregnancy; Pregnancy Complications, Neoplastic; Rituximab; Vincristine

2020
Treatment of HIV-Associated Lymphomas: The Latest Approaches for Optimizing Outcomes.
    Oncology (Williston Park, N.Y.), 2017, 12-15, Volume: 31, Issue:12

    Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, AIDS-Related; Lymphoma, Large B-Cell, Diffuse; Plasmablastic Lymphoma; Prednisone; Rituximab; Vincristine

2017
[MYC-associated B-cell lymphomas: pathophysiology and treatment].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2019, Volume: 60, Issue:3

    Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Immunohistochemistry; Lymphoma, Large B-Cell, Diffuse; Neoplasm Recurrence, Local; Prednisone; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-bcl-6; Proto-Oncogene Proteins c-myc; Rituximab; Vincristine

2019
[Treatment strategy of gray zone lymphomas].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2014, Volume: 55, Issue:10

    Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Prednisone; Rituximab; Vincristine

2014
Case report and review of immunodeficiency-associated Burkitt lymphoma.
    Clinical lymphoma, myeloma & leukemia, 2015, Volume: 15, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Doxorubicin; Etoposide; HIV Infections; Humans; Male; Methotrexate; Prednisone; Remission Induction; Rituximab; Vincristine

2015
[Treatment of Burkitt lymphoma and Burkitt-like lymphoma].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2011, Volume: 52, Issue:10

    Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Rituximab; Vincristine

2011
Challenges in the management of Burkitt's lymphoma.
    Clinical lymphoma, 2002, Volume: 3 Suppl 1

    Topics: Adult; Allopurinol; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Bleomycin; Burkitt Lymphoma; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Enzyme Inhibitors; Etoposide; HIV Infections; Humans; Ifosfamide; Leucovorin; Methotrexate; Time Factors; Treatment Outcome; Urate Oxidase; Vincristine

2002
Post-transplant Burkitt's leukemia or lymphoma. Study of five cases treated with specific intensive therapy (PETHEMA ALL-3/97 trial).
    Leukemia & lymphoma, 2003, Volume: 44, Issue:9

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Dexamethasone; Epstein-Barr Virus Infections; Etoposide; Female; Heart Transplantation; Humans; Ifosfamide; Immunosuppression Therapy; Kidney Transplantation; Leucovorin; Liver Transplantation; Male; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Postoperative Complications; Prednisone; Remission Induction; Retrospective Studies; Transplantation; Treatment Outcome; Vincristine

2003
Burkitt's lymphoma-leukemia in patients treated for Hodgkin's disease.
    Cancer investigation, 1996, Volume: 14, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Burkitt Lymphoma; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Follicular; Mechlorethamine; Mediastinal Neoplasms; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Procarbazine; Spinal Neoplasms; Thoracic Vertebrae; Vinblastine; Vincristine

1996
Burkitt's lymphoma involving the mandible: report of a case and review of Japanese cases.
    Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 1998, Volume: 85, Issue:2

    Topics: Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Cyclophosphamide; Cytarabine; Epirubicin; Etoposide; Humans; Hydrocortisone; Japan; Male; Mandibular Neoplasms; Methotrexate; Prednisone; Soft Tissue Neoplasms

1998

Trials

20 trial(s) available for etoposide and Burkitt Lymphoma

ArticleYear
A dose-dense short-term therapy for human immunodeficiency virus/acquired immunodeficiency syndrome patients with high-risk Burkitt lymphoma or high-grade B-cell lymphoma: safety and efficacy results of the "CARMEN" phase II trial.
    British journal of haematology, 2021, Volume: 192, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Burkitt Lymphoma; Carmustine; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; HIV Infections; Humans; Lymphoma, B-Cell; Male; Melphalan; Middle Aged; Transplantation, Autologous

2021
Outcome of relapse in children and adolescents with B-cell non-Hodgkin lymphoma and mature acute leukemia: A report from the French LMB study.
    Pediatric blood & cancer, 2019, Volume: 66, Issue:9

    Topics: Acute Disease; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Carboplatin; Child; Child, Preschool; Cytarabine; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; France; Humans; Ifosfamide; Infant; Leukemia; Lymphoma, Large B-Cell, Diffuse; Male; Prospective Studies; Recurrence; Rituximab; Survival Rate

2019
A multicenter phase II study incorporating high-dose rituximab and liposomal doxorubicin into the CODOX-M/IVAC regimen for untreated Burkitt's lymphoma.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2013, Volume: 24, Issue:12

    Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Polyethylene Glycols; Rituximab; Thrombocytopenia; Treatment Outcome; Vincristine; Young Adult

2013
Low-intensity therapy in adults with Burkitt's lymphoma.
    The New England journal of medicine, 2013, Nov-14, Volume: 369, Issue:20

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Doxorubicin; Etoposide; Female; HIV Seropositivity; Humans; Immunocompromised Host; Male; Middle Aged; Prednisone; Prospective Studies; Vincristine

2013
Rituximab with chemotherapy in children and adolescents with central nervous system and/or bone marrow-positive Burkitt lymphoma/leukaemia: a Children's Oncology Group Report.
    British journal of haematology, 2014, Volume: 167, Issue:3

    Topics: Adolescent; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Burkitt Lymphoma; Central Nervous System Neoplasms; Child; Consolidation Chemotherapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Genes, myc; Humans; Immunotherapy; Infusions, Intravenous; Kaplan-Meier Estimate; Lymphoma, B-Cell; Maintenance Chemotherapy; Male; Methotrexate; Prednisone; Remission Induction; Rituximab; Typhlitis; Vincristine

2014
Improved outcome of adult Burkitt lymphoma/leukemia with rituximab and chemotherapy: report of a large prospective multicenter trial.
    Blood, 2014, Dec-18, Volume: 124, Issue:26

    Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Immunotherapy; Injections, Spinal; Leukemia; Male; Methotrexate; Middle Aged; Prognosis; Prospective Studies; Remission Induction; Rituximab; Young Adult

2014
AMC 048: modified CODOX-M/IVAC-rituximab is safe and effective for HIV-associated Burkitt lymphoma.
    Blood, 2015, Jul-09, Volume: 126, Issue:2

    Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; HIV Infections; HIV-1; Humans; Ifosfamide; Male; Methotrexate; Middle Aged; Rituximab; Treatment Outcome; Vincristine; Young Adult

2015
A prospective clinicopathologic study of dose-modified CODOX-M/IVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC/NCRI LY10 trial).
    Blood, 2008, Sep-15, Volume: 112, Issue:6

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Cytogenetic Analysis; Disease-Free Survival; Doxorubicin; Etoposide; Humans; Ifosfamide; Immunophenotyping; Methotrexate; Middle Aged; Treatment Outcome; Vincristine

2008
Dose-intensified treatment of Burkitt lymphoma and B-cell lymphoma unclassifiable, (with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma) in young adults (<50 years): a comparison of two adapted BFM protocols.
    American journal of hematology, 2010, Volume: 85, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cohort Studies; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Lymphoma, B-Cell; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisolone; Survival Analysis; Vincristine; Vindesine; Young Adult

2010
Treatment of Burkitt lymphoma in equatorial Africa using a simple three-drug combination followed by a salvage regimen for patients with persistent or recurrent disease.
    British journal of haematology, 2012, Volume: 158, Issue:6

    Topics: Adolescent; Adult; Africa South of the Sahara; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cause of Death; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Mesna; Methotrexate; Middle Aged; Neoplasm Staging; Recurrence; Remission Induction; Risk; Salvage Therapy; Survival Rate; Treatment Outcome; Vincristine; Young Adult

2012
An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt's lymphoma: results of United Kingdom Lymphoma Group LY06 study.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2002, Volume: 13, Issue:8

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; L-Lactate Dehydrogenase; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prognosis; Prospective Studies; Risk Factors; Survival Rate; Treatment Outcome; United Kingdom; Vincristine

2002
Modified magrath regimens for adults with Burkitt and Burkitt-like lymphomas: preserved efficacy with decreased toxicity.
    Leukemia & lymphoma, 2004, Volume: 45, Issue:4

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Leucovorin; Mesna; Methotrexate; Middle Aged; Survival Analysis; Treatment Outcome; Vincristine

2004
Short intensive sequential therapy followed by autologous stem cell transplantation in adult Burkitt, Burkitt-like and lymphoblastic lymphoma.
    Leukemia, 2005, Volume: 19, Issue:6

    Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mitoxantrone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Transplantation, Autologous

2005
Burkitt lymphoma in adults: a prospective study of 72 patients treated with an adapted pediatric LMB protocol.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2005, Volume: 16, Issue:12

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Hydrocortisone; Leucovorin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Prospective Studies; Survival Rate; Vincristine

2005
Intensive chemotherapy regimen (LMB86) for St Jude stage IV AIDS-related Burkitt lymphoma/leukemia: a prospective study.
    Blood, 2007, Oct-15, Volume: 110, Issue:8

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Burkitt Lymphoma; CD4 Lymphocyte Count; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Kaplan-Meier Estimate; Lymphoma, AIDS-Related; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Prospective Studies; Treatment Outcome; Vincristine

2007
Short-term weekly chemotherapy followed by high-dose therapy with autologous bone marrow transplantation for lymphoblastic and Burkitt's lymphomas in adult patients.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1995, Volume: 6, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Burkitt Lymphoma; Carmustine; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Leucovorin; Male; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Survival Rate; Transplantation, Autologous; Vincristine

1995
Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage--a report of the Berlin-Frankfurt-Münster Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Clinical Protocols; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Infant; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Anaplastic; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Time Factors

1995
[Studies of childhood non-Hodgkin's lymphoma--treatment results with the CCLSG NHL 960 protocol. Children's Cancer and Leukemia Study Group (CCLSG)].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1998, Volume: 39, Issue:11

    Topics: Adolescent; Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Doxorubicin; Etoposide; Female; Humans; Hydrocortisone; Infant; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Remission Induction; Vincristine

1998
Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.
    Blood, 1999, Nov-15, Volume: 94, Issue:10

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Burkitt Lymphoma; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; L-Lactate Dehydrogenase; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Staging; Prednisolone; Treatment Outcome; Vincristine

1999
Intensive, very short-term chemotherapy for advanced Burkitt's lymphoma in children.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Jun-15, Volume: 20, Issue:12

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Central Nervous System Neoplasms; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Cytarabine; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Infusions, Intravenous; Injections, Spinal; Male; Methotrexate; Palliative Care; Prognosis; Risk Factors; Treatment Outcome; Vincristine

2002

Other Studies

78 other study(ies) available for etoposide and Burkitt Lymphoma

ArticleYear
Bis(bioreductive) alkylating agents: synthesis and biological activity in a nude mouse human carcinoma model.
    Journal of medicinal chemistry, 1983, Volume: 26, Issue:12

    Topics: Animals; Antineoplastic Agents; Benzoquinones; Burkitt Lymphoma; Cell Line; Cisplatin; Drug Resistance; Humans; Methotrexate; Mice; Mice, Nude; Nasopharyngeal Neoplasms; Quinones; Tumor Stem Cell Assay; Vinblastine

1983
Primary chest wall Burkitt lymphoma in a case of HIV infection with immune reconstitution.
    BMJ case reports, 2021, Dec-30, Volume: 14, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Doxorubicin; Etoposide; HIV Infections; Humans; Immune Reconstitution; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prednisone; Rituximab; Thoracic Wall; Vincristine

2021
Safety and efficacy of a dose-dense short-term therapy in patients with MYC-translocated aggressive lymphoma.
    Blood advances, 2022, 11-22, Volume: 6, Issue:22

    Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; COVID-19; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; HIV Infections; Humans; In Situ Hybridization, Fluorescence; Lymphoma; Lymphoma, B-Cell; Prednisone; Retrospective Studies; Rituximab; Transplantation, Autologous; Vincristine

2022
l-Asparaginase synergizes with etoposide via the PI3K/Akt/mTOR pathway in Epstein-Barr virus-positive Burkitt lymphoma.
    Journal of biochemical and molecular toxicology, 2022, Volume: 36, Issue:8

    Topics: Animals; Apoptosis; Asparaginase; Burkitt Lymphoma; Epstein-Barr Virus Infections; Etoposide; Herpesvirus 4, Human; Mice; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; TOR Serine-Threonine Kinases

2022
Multicenter Study of Risk-Adapted Therapy With Dose-Adjusted EPOCH-R in Adults With Untreated Burkitt Lymphoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2020, 08-01, Volume: 38, Issue:22

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prednisone; Prognosis; Risk Factors; Rituximab; Survival Rate; Vincristine; Young Adult

2020
Dose-adjusted EPOCH-R: a feasible alternative for Burkitt lymphoma in resource-constrained settings.
    British journal of haematology, 2020, Volume: 190, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma, Large B-Cell, Diffuse; Prednisone; United Kingdom; Vincristine

2020
Reply to M. Hertzberg et al.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2020, 11-01, Volume: 38, Issue:31

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Prednisone; Vincristine

2020
DA-EPOCH-R in Burkitt Lymphoma: Is It Enough for High-Risk Disease?
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2020, 11-01, Volume: 38, Issue:31

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Prednisone; Vincristine

2020
Nivolumab Treatment of Burkitt Lymphoma: A Case Report.
    Annals of internal medicine, 2021, Volume: 174, Issue:4

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Humans; Ifosfamide; Male; Methotrexate; Nivolumab; Vincristine

2021
Treatment of sporadic Burkitt lymphoma in adults, a retrospective comparison of four treatment regimens.
    Annals of hematology, 2018, Volume: 97, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Carmustine; Cost-Benefit Analysis; Cyclophosphamide; Cytarabine; Etoposide; Female; HIV Infections; Humans; Ifosfamide; Male; Melphalan; Methotrexate; Middle Aged; Neoplasm Staging; Retrospective Studies; Rituximab; Survival Analysis

2018
Excellent real-world outcomes of adults with Burkitt lymphoma treated with CODOX-M/IVAC plus or minus rituximab.
    British journal of haematology, 2018, Volume: 181, Issue:6

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Methotrexate; Middle Aged; Rituximab; Survival Rate; Time Factors; Vincristine

2018
Successful Use of EPOCH-R in 2 Young Adult Patients With Burkitt Lymphoma and Acute Kidney Injury: A Case Report.
    Journal of pediatric hematology/oncology, 2019, Volume: 41, Issue:6

    Topics: Acute Kidney Injury; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Down Syndrome; Doxorubicin; Etoposide; Humans; Male; Prednisone; Prognosis; Rituximab; Vincristine

2019
Impact of chemotherapy regimen and rituximab in adult Burkitt lymphoma: a retrospective population-based study from the Nordic Lymphoma Group.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2013, Volume: 24, Issue:7

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Denmark; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Multivariate Analysis; Retrospective Studies; Rituximab; Sweden; Treatment Outcome; Vincristine; Young Adult

2013
Burkitt lymphomas failing dose-adjusted R-EPOCH (DA-R-EPOCH).
    Annals of hematology, 2014, Volume: 93, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Fatal Outcome; Female; Humans; Lymphoma, AIDS-Related; Male; Multiple Organ Failure; Prednisone; Treatment Failure; Vincristine

2014
Clinical outcomes of AIDS-related Burkitt lymphoma: a multi-institution retrospective survey in Japan.
    Japanese journal of clinical oncology, 2014, Volume: 44, Issue:4

    Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Induction Chemotherapy; Japan; Kaplan-Meier Estimate; Lymphoma, AIDS-Related; Male; Methotrexate; Middle Aged; Prednisone; Retrospective Studies; Rituximab; Treatment Outcome; Vincristine

2014
Histone deacetylase inhibitor prevents cell growth in Burkitt's lymphoma by regulating PI3K/Akt pathways and leads to upregulation of miR-143, miR-145, and miR-101.
    Annals of hematology, 2014, Volume: 93, Issue:6

    Topics: Antineoplastic Agents, Phytogenic; Burkitt Lymphoma; Butyric Acid; Cell Cycle; Cell Line, Tumor; Drug Synergism; Etoposide; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genes, myc; Histone Deacetylase Inhibitors; Humans; MicroRNAs; Neoplasm Proteins; Oligonucleotide Array Sequence Analysis; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm; Signal Transduction; Tumor Suppressor Protein p53; Up-Regulation

2014
How I treat Burkitt lymphoma in adults.
    Blood, 2014, Nov-06, Volume: 124, Issue:19

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Humans; Ifosfamide; Male; Methotrexate; Nasopharyngeal Neoplasms; Prednisone; Prognosis; Translocation, Genetic; Vincristine

2014
A case of clonally distinct relapse of Burkitt lymphoma 9 years after complete remission.
    International journal of hematology, 2015, Volume: 101, Issue:5

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Base Sequence; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Genes, Immunoglobulin; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Immunoglobulin Heavy Chains; Male; Methotrexate; Molecular Sequence Data; Neoplasm Recurrence, Local; Remission Induction; V(D)J Recombination; Vincristine

2015
Dose-adjusted EPOCH-R for Burkitt lymphoma.
    Clinical advances in hematology & oncology : H&O, 2014, Volume: 12, Issue:11

    Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Prednisone; Rituximab; Treatment Outcome; Vincristine

2014
Rituximab-combination chemotherapy achieves a 10th cycle of remission for Burkitt's lymphoma.
    Pediatrics international : official journal of the Japan Pediatric Society, 2015, Volume: 57, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Carboplatin; Etoposide; Female; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Piperidines; Remission Induction; Rituximab

2015
Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphoma.
    Cancer, 2016, Feb-15, Volume: 122, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Burkitt Lymphoma; Central Nervous System Neoplasms; Cohort Studies; Cyclophosphamide; Cytarabine; Databases, Factual; Dexamethasone; DNA-Binding Proteins; Doxorubicin; Etoposide; Female; Gene Rearrangement; Genes, bcl-2; Genes, myc; Germinal Center; Humans; Ifosfamide; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Prognosis; Proto-Oncogene Proteins c-bcl-6; Rituximab; Survival Rate; Vincristine

2016
The pharmacokinetics of high-dose methotrexate in people living with HIV on antiretroviral therapy.
    Cancer chemotherapy and pharmacology, 2016, Volume: 77, Issue:3

    Topics: Adult; Aged; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Dose-Response Relationship, Drug; Doxorubicin; Drug Interactions; Etoposide; Female; Half-Life; HIV Infections; Humans; Ifosfamide; Kidney Function Tests; Male; Methotrexate; Middle Aged; Retrospective Studies; Tenofovir; Vincristine; Young Adult

2016
[Clinical and Prognostic analysis of 43 Children with Mature B-cell Non-Hodgkin's Lymphoma/Acute Lymphoblastic Leukemia].
    Zhongguo shi yan xue ye xue za zhi, 2016, Volume: 24, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Hydrocortisone; Leucovorin; Logistic Models; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Multivariate Analysis; Neoplasm Staging; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Retrospective Studies; Survival Rate; Vincristine

2016
Circulating lymphoma cells of double-hit lymphoma.
    BMJ case reports, 2016, Nov-29, Volume: 2016

    Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Doxorubicin; Etoposide; Gastrointestinal Hemorrhage; Humans; Lymphoma, B-Cell; Male; Pancytopenia; Prednisone; Treatment Outcome; Vincristine; Weight Loss

2016
Pancreatic lymphoma complicating early stage chronic hepatitis C.
    BMJ case reports, 2017, Jan-10, Volume: 2017

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Doxorubicin; Etoposide; Fatal Outcome; Female; Hepatitis C, Chronic; Humans; Pancreatic Neoplasms; Prednisone; Rituximab; Vincristine

2017
Cutaneous Ulcers Secondary to Cytomegalovirus and Herpes Simplex Virus in an Immunocompromised Patient.
    The American journal of the medical sciences, 2017, Volume: 353, Issue:2

    Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Burkitt Lymphoma; Cyclophosphamide; Cytomegalovirus; Cytomegalovirus Infections; Doxorubicin; Etoposide; Herpes Simplex; Humans; Immunocompromised Host; Male; Rituximab; Simplexvirus; Skin Ulcer

2017
Outcomes of adults with relapsed or refractory Burkitt and high-grade B-cell leukemia/lymphoma.
    American journal of hematology, 2017, Volume: 92, Issue:6

    Topics: Adult; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Cyclophosphamide; Dexamethasone; Disease-Free Survival; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Leukemia, B-Cell; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Methotrexate; Polyethylene Glycols; Prednisone; Recurrence; Remission Induction; Retrospective Studies; Rituximab; Salvage Therapy; Treatment Outcome; Vincristine

2017
Efficacy of continuous venovenous hemofiltration with chemotherapy in patients with Burkitt lymphoma and leukemia at high risk of tumor lysis syndrome.
    Annals of hematology, 2009, Volume: 88, Issue:7

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hemofiltration; Humans; Hydrocortisone; Hyperuricemia; Kidney Function Tests; Leucovorin; Male; Methotrexate; Middle Aged; Prednisone; Prognosis; Retrospective Studies; Risk; Survival Analysis; Tumor Lysis Syndrome; Vincristine

2009
Treatment outcome of adult patients with Burkitt lymphoma: results using the LMB protocol in Korea.
    Annals of hematology, 2009, Volume: 88, Issue:11

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Drug Evaluation; Etoposide; Female; Hematologic Diseases; Humans; Kaplan-Meier Estimate; Korea; Male; Methotrexate; Middle Aged; Prednisone; Prognosis; Proportional Hazards Models; Retrospective Studies; Risk Factors; Sepsis; Treatment Outcome; Vincristine; Young Adult

2009
Activation of p53 by MDM2 antagonists has differential apoptotic effects on Epstein-Barr virus (EBV)-positive and EBV-negative Burkitt's lymphoma cells.
    Leukemia, 2009, Volume: 23, Issue:9

    Topics: Apoptosis; Burkitt Lymphoma; Cell Cycle; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Drug Resistance, Neoplasm; Etoposide; Herpesvirus 4, Human; Humans; Imidazoles; Piperazines; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-mdm2; Tumor Suppressor Protein p53

2009
Chemotherapy-induced palmoplantar erythrodysesthesia in a child with Burkitt lymphoma.
    Pediatric blood & cancer, 2009, Volume: 53, Issue:4

    Topics: Antineoplastic Agents; Burkitt Lymphoma; Child, Preschool; Cytarabine; Etoposide; Foot Dermatoses; Hand Dermatoses; Humans; Male; Paresthesia

2009
Insights into apoptosis mechanisms induced by DNA-damaging agents in Burkitt's lymphoma cells.
    Cancer investigation, 2009, Volume: 27, Issue:8

    Topics: Antineoplastic Agents; Apoptosis; Burkitt Lymphoma; Cell Cycle; Cell Line, Tumor; Cisplatin; Cyclin-Dependent Kinase Inhibitor p21; DNA Damage; Doxorubicin; Etoposide; Gamma Rays; Gene Expression Regulation, Neoplastic; Humans; Inhibitor of Apoptosis Proteins; Microtubule-Associated Proteins; Mutation; Survivin; Time Factors; Tumor Suppressor Protein p53

2009
[Successful treatment with hyper-CVAD and highly active anti-retroviral therapy (HAART) for AIDS-related Burkitt lymphoma].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2010, Volume: 51, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Burkitt Lymphoma; Colonic Neoplasms; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Humans; Lymphoma, AIDS-Related; Male; Methotrexate; Prednisone; Treatment Outcome; Vincristine

2010
EBV interferes with the sensitivity of Burkitt lymphoma Akata cells to etoposide.
    Journal of cellular biochemistry, 2011, Volume: 112, Issue:1

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; bcl-X Protein; Burkitt Lymphoma; Cell Line, Tumor; Down-Regulation; Epstein-Barr Virus Nuclear Antigens; Etoposide; Herpesvirus 4, Human; Humans; RNA, Messenger; RNA, Small Interfering; Viral Matrix Proteins

2011
Modified cyclophosphamide, vincristine, doxorubicin, and methotrexate (CODOX-M)/ifosfamide, etoposide, and cytarabine (IVAC) therapy with or without rituximab in Japanese adult patients with Burkitt lymphoma (BL) and B cell lymphoma, unclassifiable, with
    International journal of hematology, 2010, Volume: 92, Issue:5

    Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, B-Cell; Male; Methotrexate; Middle Aged; Rituximab; Treatment Outcome; Vincristine; Young Adult

2010
Evaluation of the addition of rituximab to CODOX-M/IVAC for Burkitt's lymphoma: a retrospective analysis.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2011, Volume: 22, Issue:8

    Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; HIV Infections; Humans; Ifosfamide; Male; Methotrexate; Middle Aged; Retrospective Studies; Rituximab; Secondary Prevention; Vincristine

2011
MRP1 expressed on Burkitt's lymphoma cells was depleted by catfish egg lectin through Gb3-glycosphingolipid and enhanced cytotoxic effect of drugs.
    The protein journal, 2012, Volume: 31, Issue:1

    Topics: Animals; Antineoplastic Agents; Burkitt Lymphoma; Catfishes; Cell Line, Tumor; Etoposide; Fish Proteins; Gene Expression Regulation, Neoplastic; Glycosphingolipids; Humans; Lectins; Multidrug Resistance-Associated Proteins; Ovum; Protein Binding; Trisaccharides; Vincristine

2012
Treatment outcome of adult Burkitt Lymphoma in Japanese patients with modified LMB protocol : a single center retrospective analysis.
    Journal of clinical and experimental hematopathology : JCEH, 2011, Volume: 51, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Japan; Male; Methotrexate; Middle Aged; Prognosis; Retrospective Studies; Treatment Outcome; Vincristine; Young Adult

2011
Histone deacetylase inhibitor potentiates chemotherapy-induced apoptosis through Bim upregulation in Burkitt's lymphoma cells.
    Journal of cancer research and clinical oncology, 2012, Volume: 138, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; Bcl-2-Like Protein 11; Burkitt Lymphoma; Butyrates; Caspase 3; Caspase 9; Cell Line, Tumor; Cisplatin; Dose-Response Relationship, Drug; Down-Regulation; Drug Synergism; Etoposide; Histone Deacetylase Inhibitors; Humans; Membrane Proteins; Myeloid Cell Leukemia Sequence 1 Protein; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Up-Regulation

2012
Successful treatment of ICE-rituximab chemotherapy and subsequent bone marrow transplantation in a patient with early-relapse Burkitt leukemia and inverted duplication of 1q.
    Journal of pediatric hematology/oncology, 2012, Volume: 34, Issue:2

    Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Burkitt Lymphoma; Carboplatin; Child; Chromosome Duplication; Chromosomes, Human, Pair 1; Etoposide; Humans; Ifosfamide; Male; Mesna; Neoplasm Recurrence, Local; Rituximab

2012
Tailored chemotherapy for malignant lymphoma arising in the setting of posttransplant lymphoproliferative disorder after solid organ transplantation.
    Journal of pediatric hematology/oncology, 2002, Volume: 24, Issue:8

    Topics: Algorithms; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Burkitt Lymphoma; Chemotherapy, Adjuvant; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Epstein-Barr Virus Infections; Etoposide; Fatal Outcome; Female; Heart Transplantation; Humans; Immunosuppression Therapy; Kidney Transplantation; Lung Neoplasms; Lymphoma, AIDS-Related; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoproliferative Disorders; Male; Methotrexate; Postoperative Complications; Prednisone; Remission Induction; Stomach Neoplasms; Survival Analysis; Treatment Outcome; Vincristine

2002
High survival rate in childhood non-Hodgkin lymphoma without CNS involvement: results of BFM 95 study in Kuwait.
    Pediatric hematology and oncology, 2003, Volume: 20, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Kuwait; Leucovorin; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Mercaptopurine; Mesna; Methotrexate; Neoplasm Staging; Prednisolone; Prednisone; Survival Rate; Thioguanine; Treatment Outcome; Vincristine

2003
Induction of long-term remission of a relapsed childhood B-acute lymphoblastic leukemia with rituximab chimeric anti-CD20 monoclonal antibody and autologous stem cell transplantation.
    Journal of pediatric hematology/oncology, 2003, Volume: 25, Issue:4

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Burkitt Lymphoma; Child; Combined Modality Therapy; Cytarabine; Dexamethasone; Etoposide; Humans; Immunotherapy; Leukemic Infiltration; Male; Meninges; Methotrexate; Peripheral Blood Stem Cell Transplantation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Remission Induction; Rituximab; Salvage Therapy; Testis; Topotecan; Transplantation, Autologous; Vindesine

2003
Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/IVAC) for human immunodeficiency virus-associated Burkitt lymphoma.
    Cancer, 2003, Sep-15, Volume: 98, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, AIDS-Related; Male; Methotrexate; Middle Aged; Retrospective Studies

2003
Stromal cell protection of B-lineage acute lymphoblastic leukemic cells during chemotherapy requires active Akt.
    Leukemia research, 2004, Volume: 28, Issue:7

    Topics: Animals; Antineoplastic Agents; Burkitt Lymphoma; Cell Survival; Coculture Techniques; Cytarabine; Etoposide; Humans; Mice; Phosphoprotein Phosphatases; Phosphorylation; Poly(ADP-ribose) Polymerases; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Stromal Cells

2004
[Treatment of childhood Burkitt lymphoma according to LMB89 protocol in Casablanca].
    Bulletin du cancer, 2005, Volume: 92, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Hydrocortisone; Infant; Leucovorin; Male; Methotrexate; Prednisone; Recurrence; Remission Induction; Survival Analysis; Vincristine

2005
A Case of Burkitt's Lymphoma Involving Both Breasts.
    Breast cancer (Tokyo, Japan), 2005, Volume: 12, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Dexamethasone; Diagnostic Errors; Doxorubicin; Etoposide; Fatal Outcome; Female; Humans; Lymphoma, B-Cell; Peripheral Blood Stem Cell Transplantation; Prednisone; Vincristine

2005
Combined spectral karyotyping, comparative genomic hybridization, and in vitro apoptyping of a panel of Burkitt's lymphoma-derived B cell lines reveals an unexpected complexity of chromosomal aberrations and a recurrence of specific abnormalities in chemo
    International journal of oncology, 2006, Volume: 28, Issue:3

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; B-Lymphocytes; Burkitt Lymphoma; Cell Line, Tumor; Chromosome Aberrations; Chromosome Banding; Chromosome Breakage; DNA, Neoplasm; Drug Resistance, Neoplasm; Etoposide; Female; Genome, Human; Humans; Male; Nucleic Acid Hybridization; Polymerase Chain Reaction; Spectral Karyotyping; Translocation, Genetic

2006
False-positive restaging PET scans involving the spleen in two patients with aggressive non-Hodgkin lymphoma.
    Clinical nuclear medicine, 2006, Volume: 31, Issue:7

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Burkitt Lymphoma; Carboplatin; Cyclophosphamide; Dexamethasone; Disease Progression; Doxorubicin; Etoposide; False Positive Reactions; Humans; Ifosfamide; Laparoscopy; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Necrosis; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Remission Induction; Rituximab; Salvage Therapy; Spleen; Splenectomy; Tomography, X-Ray Computed; Unnecessary Procedures; Vincristine

2006
Treatment of Burkitt's lymphoma during pregnancy.
    The Annals of pharmacotherapy, 2006, Volume: 40, Issue:11

    Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant, Newborn; Male; Methotrexate; Pregnancy; Pregnancy Complications, Neoplastic; Registries; Vincristine

2006
Treatment of HIV-associated Burkitt Lymphoma in the presence of severe hepatic dysfunction.
    Clinical advances in hematology & oncology : H&O, 2006, Volume: 4, Issue:11

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Doxorubicin; Epirubicin; Etoposide; HIV Infections; Humans; Liver Diseases; Male; Prednisone; Remission Induction; Vincristine

2006
Chemotherapy and zoledronate sensitize solid tumour cells to Vgamma9Vdelta2 T cell cytotoxicity.
    Cancer immunology, immunotherapy : CII, 2007, Volume: 56, Issue:8

    Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Burkitt Lymphoma; Carcinoma; Cell Line, Tumor; Cisplatin; Colorectal Neoplasms; Concanavalin A; Cytotoxicity, Immunologic; Diphosphonates; Doxorubicin; Drug Screening Assays, Antitumor; Drug Synergism; Etoposide; Female; Genes, T-Cell Receptor delta; Genes, T-Cell Receptor gamma; Humans; Imidazoles; Interferon-gamma; Lovastatin; Lung Neoplasms; Male; Membrane Glycoproteins; Neoplasms; Perforin; Pore Forming Cytotoxic Proteins; Prostatic Neoplasms; Receptors, Antigen, T-Cell, gamma-delta; T-Lymphocyte Subsets; Urinary Bladder Neoplasms; Vincristine; Zoledronic Acid

2007
CODOX-M/IVAC (NCI 89-C-41) in children and adolescents with Burkitt's leukemia/lymphoma and large B-cell lymphomas: a 15-year monocentric experience.
    Leukemia & lymphoma, 2007, Volume: 48, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Leukemia; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Risk Factors; Survival Rate; Treatment Outcome; Vincristine

2007
[Early relapse of Burkitt's lymphoma with t(8;14) and t(14;18) after rituximab-combined CODOX-M and IVAC therapy].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2007, Volume: 48, Issue:4

    Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Chromosomes, Human, Pair 14; Chromosomes, Human, Pair 8; Cyclophosphamide; Cytarabine; Disease Progression; Doxorubicin; Etoposide; Fatal Outcome; Female; Humans; Ifosfamide; Methotrexate; Recurrence; Remission Induction; Rituximab; Translocation, Genetic; Vincristine

2007
Primary hepatic Burkitt lymphoma.
    Pediatric hematology and oncology, 2008, Volume: 25, Issue:4

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Cytarabine; Etoposide; Humans; Ifosfamide; Liver Neoplasms; Magnetic Resonance Imaging; Male

2008
Anti-B4-blocked ricin synergizes with doxorubicin and etoposide on multidrug-resistant and drug-sensitive tumors.
    Blood, 1995, Dec-01, Volume: 86, Issue:11

    Topics: Animals; Antigens, CD19; ATP Binding Cassette Transporter, Subfamily B, Member 1; Burkitt Lymphoma; Doxorubicin; Drug Resistance, Multiple; Drug Synergism; Etoposide; Genotype; Humans; Immunotoxins; Mice; Mice, SCID; Ricin; Tumor Cells, Cultured

1995
p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents.
    Cancer research, 1994, Nov-15, Volume: 54, Issue:22

    Topics: Apoptosis; Burkitt Lymphoma; Cisplatin; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; DNA Topoisomerases, Type II; Drug Resistance; Etoposide; Flow Cytometry; G1 Phase; Gamma Rays; Genes, p53; Humans; Lymphocytes; Mechlorethamine; Mutation; Nocodazole; Radiation Tolerance; RNA, Messenger; Tumor Cells, Cultured; Tumor Suppressor Protein p53

1994
Secondary acute myeloid leukemia in children with acute lymphoblastic leukemia treated with etoposide.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1993, Volume: 11, Issue:2

    Topics: Acute Disease; Adolescent; Bone Marrow; Burkitt Lymphoma; Child; Child, Preschool; Etoposide; Female; Humans; Infant; Leukemia, Myeloid; Male; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Risk; Treatment Outcome

1993
Degradation of radioiodinated B cell monoclonal antibodies: inhibition via a FCgamma-receptor-II-mediated mechanism and by drugs.
    Cancer immunology, immunotherapy : CII, 1996, Volume: 42, Issue:1

    Topics: Animals; Antibodies, Monoclonal; Antigens, CD; Antigens, CD19; Antigens, Differentiation, B-Lymphocyte; Antineoplastic Agents; B-Lymphocytes; Biological Transport; Burkitt Lymphoma; Calcium Channel Blockers; Cell Adhesion Molecules; Chloroquine; Colchicine; Etoposide; Humans; Immunoglobulin Isotypes; Immunotoxins; Iodine Radioisotopes; Lectins; Leukemia, B-Cell; Mice; Monensin; Paclitaxel; Radioimmunotherapy; Receptors, IgG; Sialic Acid Binding Ig-like Lectin 2; Verapamil; Vinblastine; Vincristine

1996
A comparison of a CB17 scid mouse model and the tetrazolium-dye assay using human haematological tumour cell lines.
    Cancer chemotherapy and pharmacology, 1996, Volume: 38, Issue:6

    Topics: Animals; Antineoplastic Agents; Burkitt Lymphoma; Coloring Agents; Daunorubicin; Disease Models, Animal; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Etoposide; Female; Humans; Idarubicin; Leukemia, Experimental; Male; Mice; Mice, SCID; Multiple Myeloma; Tetrazolium Salts; Toxicity Tests; Tumor Cells, Cultured

1996
Epstein-Barr virus associated Burkitt lymphoma in a heart transplant recipient.
    Transplantation, 1996, Sep-27, Volume: 62, Issue:6

    Topics: Allopurinol; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Burkitt Lymphoma; Cyclophosphamide; Cyclosporine; Cytarabine; Doxorubicin; Etoposide; Heart Transplantation; Herpesviridae Infections; Herpesvirus 4, Human; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Postoperative Complications; Prednisolone; Remission Induction; T-Lymphocytes, Cytotoxic; Tumor Virus Infections; Vincristine

1996
Autologous bone marrow transplantation in relapsed HIV-related non-Hodgkin's lymphoma.
    Bone marrow transplantation, 1996, Volume: 18, Issue:6

    Topics: Adult; AIDS-Related Opportunistic Infections; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Burkitt Lymphoma; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Duodenal Neoplasms; Etoposide; Humans; Immunocompromised Host; Lymphoma, AIDS-Related; Lymphoma, Large B-Cell, Diffuse; Male; Methylprednisolone; Neoplasms, Second Primary; Pancytopenia; Remission Induction; Salvage Therapy; Thigh; Transplantation Conditioning; Vincristine

1996
Resistance to etoposide-induced apoptosis in a Burkitt's lymphoma cell line.
    International journal of cancer, 1998, Aug-31, Volume: 77, Issue:5

    Topics: Apoptosis; Burkitt Lymphoma; Cell Line; Cell Nucleus; Cell-Free System; Cytoplasm; DNA-Activated Protein Kinase; DNA-Binding Proteins; Drug Resistance, Neoplasm; Etoposide; Herpesvirus 4, Human; Humans; Nuclear Proteins; Protein Serine-Threonine Kinases; Proto-Oncogene Mas

1998
[Successful treatment with high dose chemotherapy following peripheral blood stem cell transplantation for relapsed Burkitt's lymphoma with central nervous system involvement].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1998, Volume: 39, Issue:11

    Topics: Adult; Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Carboplatin; Central Nervous System Neoplasms; Cyclophosphamide; Cytarabine; Dexamethasone; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Transplantation, Autologous

1998
[Reye syndrome in a child having received chemotherapy].
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 1998, Volume: 5, Issue:3

    Topics: Abdominal Neoplasms; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Humans; Male; Methotrexate; Prednisone; Reye Syndrome; Vincristine

1998
Oxidative stress inhibits apoptosis in human lymphoma cells.
    The Journal of biological chemistry, 1999, Jul-09, Volume: 274, Issue:28

    Topics: Adenosine Triphosphate; Annexin A5; Apoptosis; Benzamides; Burkitt Lymphoma; Calcimycin; Caspase Inhibitors; Caspases; DNA Fragmentation; Etoposide; Humans; Hydrogen Peroxide; Oligomycins; Oxidative Stress; Protein Binding; Quinazolines; Quinazolinones; Tumor Cells, Cultured

1999
[Burkitt's lymphoma--a case report].
    Praxis, 1999, Sep-02, Volume: 88, Issue:36

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Diagnosis, Differential; Epirubicin; Etoposide; Female; Humans; Methotrexate; Prednisone; Vincristine

1999
Epigenetic determinants of resistance to etoposide regulation of Bcl-X(L) and Bax by tumor microenvironmental factors.
    Journal of the National Cancer Institute, 2000, Jan-05, Volume: 92, Issue:1

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Burkitt Lymphoma; Cell Survival; Drug Resistance, Neoplasm; Etoposide; Humans; Integrin alpha4beta1; Integrins; Interleukin-4; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Receptors, Lymphocyte Homing; Signal Transduction; Tumor Cells, Cultured; Vascular Cell Adhesion Molecule-1

2000
Cleavage of polypeptide chain initiation factor eIF4GI during apoptosis in lymphoma cells: characterisation of an internal fragment generated by caspase-3-mediated cleavage.
    Cell death and differentiation, 2000, Volume: 7, Issue:7

    Topics: Apoptosis; Blotting, Western; Burkitt Lymphoma; Caspase 3; Caspases; Cell Cycle; Cycloheximide; DNA; Endopeptidases; Etoposide; Eukaryotic Initiation Factor-4E; Eukaryotic Initiation Factor-4G; Humans; Nucleic Acid Synthesis Inhibitors; Peptide Chain Initiation, Translational; Peptide Fragments; Peptide Initiation Factors; Protein Biosynthesis; Protein Synthesis Inhibitors; Tumor Cells, Cultured

2000
Oxidative stress interferes with cancer chemotherapy: inhibition of lymphoma cell apoptosis and phagocytosis.
    Blood, 2000, Jul-01, Volume: 96, Issue:1

    Topics: Antineoplastic Agents; Apoptosis; Burkitt Lymphoma; Cell Membrane Permeability; Cell Nucleus; Cisplatin; Cytarabine; Doxorubicin; Etoposide; Humans; Hydrogen Peroxide; Kinetics; Oxidative Stress; Phagocytosis; Tumor Cells, Cultured

2000
Outcome of relapsed or refractory childhood B-cell acute lymphoblastic leukaemia and B-cell non-Hodgkin's lymphoma treated with the UKCCSG 9003/9002 protocols.
    British journal of haematology, 2001, Volume: 112, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Burkitt Lymphoma; Child; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Lymphoma, B-Cell; Palliative Care; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Treatment Outcome; Vincristine

2001
Hepatocyte growth factor (HGF) protects c-met-expressing Burkitt's lymphoma cell lines from apoptotic death induced by DNA damaging agents.
    European journal of cancer (Oxford, England : 1990), 2001, Volume: 37, Issue:12

    Topics: Animals; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Blotting, Western; Burkitt Lymphoma; DNA Damage; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Flow Cytometry; Hepatocyte Growth Factor; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-met; Tumor Cells, Cultured

2001
Induction of apoptosis by chemotherapeutic drugs without generation of reactive oxygen species.
    Archives of biochemistry and biophysics, 2002, Jan-15, Volume: 397, Issue:2

    Topics: Acetylcysteine; Antineoplastic Agents; Antioxidants; Apoptosis; Burkitt Lymphoma; Cisplatin; Cyclic N-Oxides; Etoposide; F2-Isoprostanes; Humans; Hydrogen Peroxide; Metalloporphyrins; Methionine; Oxidants; Reactive Oxygen Species; Spin Labels

2002
Sustained complete remission following a combination of very low intensity chemotherapy with rituximab in an elderly patient with Burkitt's lymphoma.
    Haematologica, 2002, Volume: 87, Issue:1

    Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Burkitt Lymphoma; Carcinoma, Intraductal, Noninfiltrating; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Immunotherapy; Mastectomy, Segmental; Neoplasms, Multiple Primary; Orbital Neoplasms; Prednisone; Radiotherapy, Adjuvant; Remission Induction; Rituximab; Salvage Therapy; Vincristine

2002
An MCL1-overexpressing Burkitt lymphoma subline exhibits enhanced survival on exposure to serum deprivation, topoisomerase inhibitors, or staurosporine but remains sensitive to 1-beta-D-arabinofuranosylcytosine.
    Cancer research, 2002, Feb-01, Volume: 62, Issue:3

    Topics: Antimetabolites, Antineoplastic; Apoptosis; Burkitt Lymphoma; Camptothecin; Cell Survival; Culture Media, Serum-Free; Cytarabine; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Enzyme Inhibitors; Etoposide; Humans; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Proteins; Proto-Oncogene Proteins c-bcl-2; Staurosporine; Topoisomerase Inhibitors; Tumor Cells, Cultured

2002
[Cellular pharmacokinetics of melphalan alone or in combination on human lymphoma or lymphoblasts].
    Bulletin du cancer, 1989, Volume: 76, Issue:8

    Topics: Antimetabolites; Blastomeres; Burkitt Lymphoma; Buthionine Sulfoximine; Cell Line; Etoposide; Humans; Lymphocytes; Melphalan; Methionine Sulfoximine; Verapamil

1989
Fractionated total body irradiation and high-dose VP 16-213 followed by allogeneic bone marrow transplantation in advanced leukemias.
    Blood, 1988, Volume: 72, Issue:5

    Topics: Adolescent; Adult; Bone Marrow Transplantation; Burkitt Lymphoma; Child; Combined Modality Therapy; Dose-Response Relationship, Drug; Etoposide; Graft vs Host Disease; Humans; Leukemia; Leukemia, Myeloid, Acute; Middle Aged; Prognosis; Whole-Body Irradiation

1988
Intraocular involvement of Burkitt's lymphoma in a Bedouin child.
    Pediatric hematology and oncology, 1987, Volume: 4, Issue:4

    Topics: Abdominal Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Burkitt Lymphoma; Carmustine; Child, Preschool; Cyclophosphamide; Cytarabine; Etoposide; Eye Neoplasms; Female; Humans; Hydrocortisone; Methotrexate; Vincristine; Vitreous Body

1987